Last 1,899 GBp
Change Today -1.00 / -0.05%
Volume 73.4K
SYR On Other Exchanges
Symbol
Exchange
OTC US
London
As of 11:35 AM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

synergy health plc (SYR) Snapshot

Open
1,883 GBp
Previous Close
1,900 GBp
Day High
1,924 GBp
Day Low
1,883 GBp
52 Week High
11/6/14 - 2,021 GBp
52 Week Low
12/9/13 - 1,015 GBp
Market Cap
1.1B
Average Volume 10 Days
199.0K
EPS TTM
0.60 GBp
Shares Outstanding
59.0M
EX-Date
11/20/14
P/E TM
31.6x
Dividend
15.78 GBp
Dividend Yield
0.83%
Current Stock Chart for SYNERGY HEALTH PLC (SYR)

Related News

No related news articles were found.

synergy health plc (SYR) Related Businessweek News

No Related Businessweek News Found

synergy health plc (SYR) Details

Synergy Health plc provides outsourced sterilization services for medical device manufacturers, hospitals, and other industries worldwide. The company operates through the UK & Ireland, Europe & the Middle East, Asia & Africa, and the Americas segments. It offers hospital sterilization services for reusable medical and surgical equipment used in operating theatres. The company also provides a range of sterilization technologies, including gamma irradiation; electron, ion, and X-ray beam treatments; and ethylene oxide sterilization solutions for the medical devices, pharmaceuticals, and industrial sectors. In addition, it offers reusable surgical solutions comprising gowns, towels, and stainless products to hospitals and surgery centers; and laboratory services, including hematology, immunology, biochemistry, microbiology, environmental monitoring, and substance identification, as well as drug and alcohol testing services. Further, the company provides pharmaceutical laboratories for chemical and microbiological analysis; linen management services for healthcare facilities. Additionally, it offers infection prevention and control products, such as disinfectants, detergent wipes, cleaning and disinfection products, anti microbial hand sanitizing mousse, clinical waste containers, and sharps; patient hygiene solutions, including skin cleansings and bed bath systems; and custom procedure packs and trays, single use instruments, consumables, X ray detectable swabs, and bags for endoscopic retrieval of tissue. The company also offers wound care solutions, including tubular bandages, garments, and hosiery and liner kits; and IT services. Synergy Health plc was founded in 1991 and is headquartered in Swindon, the United Kingdom.

5,005 Employees
Last Reported Date: 06/30/14
Founded in 1991

synergy health plc (SYR) Top Compensated Officers

Group Chief Executive Officer, Member of Seni...
Total Annual Compensation: 823.0K GBP
Group Finance Director, Member of Senior Exec...
Total Annual Compensation: 494.0K GBP
Compensation as of Fiscal Year 2014.

synergy health plc (SYR) Key Developments

Synergy Health plc Announces Unaudited Consolidated Earnings Results for the Six Months Ended September 28, 2014

Synergy Health plc announced unaudited consolidated earnings results for the six months ended September 28, 2014. For the six months, the company reported revenue of GBP 197.5 million against GBP 192.1 million a year ago. Adjusted operating profit was GBP 31.6 million against GBP 29.2 million a year ago. Adjusted profit before tax was GBP 28.4 million against GBP 26.0 million a year ago. Profit before tax was GBP 24.7 million against GBP 21.4 million a year ago. Profit for the period was GBP 18.4 million against GBP 17.0 million a year ago. Adjusted diluted earnings per share were 36.12 pence against 32.94 pence a year ago. Diluted earnings per share were 30.75 pence against 28.27 pence a year ago. Adjusted EBITDA was GBP 51.9 million against GBP 51.2 million a year ago. Net cash from operating activities was GBP 38.067 million against GBP 38.775 million a year ago. Purchase of property, plant and equipment was GBP 32.087 million against GBP 20.893 million a year ago. Purchase of intangible assets was GBP 1.104 million against GBP 0.731 million a year ago. Net debt increased in the period from GBP 147.6 million at the end of March 2014 to GBP 172.8 million. The increase in net debt is primarily a result of the acquisition of Bioster S.p.A. in the period.

Synergy Health plc, H1 2015 Earnings Call, Nov 05, 2014

Synergy Health plc, H1 2015 Earnings Call, Nov 05, 2014

Steris Corp., Synergy Health plc - M&A Call

To discuss the acquisition of Synergy Health

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SYR:LN 1,899.00 GBp -1.00

SYR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Almirall SA €13.19 EUR +0.22
Ironwood Pharmaceuticals Inc $13.84 USD +0.17
Nektar Therapeutics $14.67 USD +0.35
Sucampo Pharmaceuticals Inc $11.68 USD -0.03
Theravance Inc $13.97 USD -0.04
View Industry Companies
 

Industry Analysis

SYR

Industry Average

Valuation SYR Industry Range
Price/Earnings 30.7x
Price/Sales 2.8x
Price/Book 3.1x
Price/Cash Flow 24.7x
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNERGY HEALTH PLC, please visit www.synergyhealthplc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.